Ed Groleau, Director, Sr. Director Supply Management And Readiness Team (SMART) at PCI Pharma Services, delivers expert insights into the evolving complexities of clinical supply management for bringing new therapies to market.
With over 30 years of experience in pharmaceutical drug development on both the pharma and vendor sides, I joined PCI in 2018 and became Sr. Director of PCI’s Supply Management And Readiness Team (SMART).
I lead an outstanding Clinical Supplies Management (CSM) group within the industry. SMART is an advanced and expanded CSM group with the experience and expertise to provide consultation and oversight for all aspects of material management for clinical trials. We offer customizable individual support that can adjust and expand as the customer’s clinical program evolves throughout the development cycle.
The pharmaceutical industry is experiencing rapid changes, especially in biologics and cell & gene therapies, that are resetting pharmaceutical development. The industry and regulations are still trying to keep up with the speed at which technology is enabling previously unimaginable treatments and cures for diseases. This is an extremely exciting time to be a part of the pharmaceutical development process. Clinical Supply Management needs to adapt to the specialized demands of trials of biologic materials. Processes that focus on real-time monitoring of shipping conditions and geo-tracking will be needed, and expertise in international distribution will be required.
We are committed to supporting clients at every stage of the manufacturing cycle, delivering best-in-class services efficiently and effectively.
Find out more about our fully integrated Clinical Services.
